Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
about
Glucagon secretion and signaling in the development of diabetesHyperglycemia induced by pasireotide in patients with Cushing's disease or acromegalyDiabetes in Patients With Acromegaly.Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic ratsAmelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.Glucose decouples intracellular Ca2+ activity from glucagon secretion in mouse pancreatic islet alpha-cellsSelective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in micePhase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumorsSSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells.Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.The somatostatin receptor subtype 5 in neuroendocrine tumours.Adverse events associated with somatostatin analogs in acromegaly.Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice.Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma.Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues.Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q21129250-281BBFC0-F110-4068-A147-C2C15D5E6005Q28069603-53E7EB98-7A39-4F3F-8A65-0D2AC508D469Q30238646-04C045AC-5D78-4CB5-BC55-3013A66A891FQ34234967-F9C43CA3-B629-42FE-B739-DFB90F49483CQ34329427-BCF7640C-3F60-4DB6-BF37-2BAB8429ACE1Q34450543-20440DD6-3861-4B28-8D44-C877DB3666BDQ35268662-02193117-97D2-42E7-92C2-35A4D7B5848DQ35747137-2F23776D-0E9E-473B-8312-2DF3A753D270Q36382533-99CFE503-1006-444A-B11A-944D36AB472EQ36911589-C03FF083-6F89-4AFA-91EE-15D26A2110D4Q36990184-954F951F-DAC4-4A26-ACC0-8BFD3E952B9FQ37691450-E0C91399-EFBD-4CD3-A7AB-59108EEBB997Q38548973-D67669C7-1038-484E-8D26-0DA5F8FA3DA7Q38912799-FDE3C314-5A81-4B44-B040-4197EC85A4F1Q39146196-41BE714F-4E7A-414C-A918-4EFE16269D46Q39164157-9ED08E5B-C575-44CB-96A7-DF78398B4A8DQ41354110-179F3532-735D-487F-BF61-EF422BFC9B80Q42138516-005A9AEF-24CC-45AD-A317-956C60126664Q43083184-8F0B6595-1587-4BB0-AEFB-2054558BBA7DQ48152509-B97B5A97-D527-4C35-8219-4A32AC2F2BC4Q51374462-E9AB3D7B-89C0-4E01-A232-62494DEE0E18Q57142659-8B8E60C1-8BD1-4F17-86BD-C4FB2003F94AQ57144951-3EF63C3A-0E3C-4D71-9ABC-C3AC0246A3BF
P2860
Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Characterization of somatostat ...... lated human pancreatic islets.
@en
Characterization of somatostat ...... lated human pancreatic islets.
@nl
type
label
Characterization of somatostat ...... lated human pancreatic islets.
@en
Characterization of somatostat ...... lated human pancreatic islets.
@nl
prefLabel
Characterization of somatostat ...... lated human pancreatic islets.
@en
Characterization of somatostat ...... lated human pancreatic islets.
@nl
P2093
P356
P1476
Characterization of somatostat ...... lated human pancreatic islets.
@en
P2093
Bertram Wiedenmann
Henning Jahr
Mathias D Brendel
Mathias Z Strowski
Reinhard G Bretzel
Stefan Mergler
Sylvia Zacharias
Ursula Plöckinger
Vandana Singh
P304
P356
10.1210/JC.2006-1578
P407
P577
2006-11-14T00:00:00Z